Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy

Author： Iessi Elisabetta   Logozzi Mariantonia   Mizzoni Davide   Di Raimo Rossella   Supuran Claudiu T.   Fais Stefano  

Publisher： MDPI

E-ISSN： 2218-1989|8|1|2-2

ISSN： 2218-1989

Source： Metabolites, Vol.8, Iss.1, 2017-12, pp. : 2-2

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Marine-Derived Angiogenesis Inhibitors for Cancer Therapy

By Wang Ying-Qing   Miao Ze-Hong  

Marine Drugs, Vol. 11, Iss. 3, 2013-03 ,pp. : 903-933

MDPI

Access to resources Recommend Favorite

Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel

By Feng Li-Xia   Li Min   Liu Yong-Jun   Yang Shao-Mei   Zhang Na  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 4201-4220

MDPI

Access to resources Recommend Favorite

Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities

By Olivo Malini   Bhuvaneswari Ramaswamy   Lucky Sasidharan Swarnalatha   Dendukuri Nagamani   Thong Patricia Soo-Ping  

Pharmaceuticals, Vol. 3, Iss. 5, 2010-05 ,pp. : 1507-1529

MDPI

Access to resources Recommend Favorite

Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy

By Ström Cecilia E.   Helleday Thomas  

Biomolecules, Vol. 2, Iss. 4, 2012-12 ,pp. : 635-649

MDPI

Access to resources Recommend Favorite

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension

By Niemeijer Menco G.   Cleophas Ton J.  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 125-133

MDPI

Access to resources Recommend Favorite